Search Results

Refine Results
  1. Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development

    Published in Oncolytic Virotherapy (2020)
    Get full text
    Online Article RSS Article
  2. Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma Virus

    Published in Oncolytic Virotherapy (2019)
    Get full text
    Online Article RSS Article
  3. Virus–Receptor Interactions: Structural Insights For Oncolytic Virus Development

    Published in Oncolytic Virotherapy (2019)
    Get full text
    Online Article RSS Article
  4. Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma

    Published in Oncolytic Virotherapy (2019)
    Get full text
    Online Article RSS Article
  5. Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes

    Published in Oncolytic Virotherapy (2019)
    Get full text
    Online Article RSS Article
  6. A cautionary note on the selectivity of oncolytic poxviruses

    Published in Oncolytic Virotherapy (2019)
    Get full text
    Online Article RSS Article
  7. Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma [Corrigendum]

    Published in Oncolytic Virotherapy (2019)
    Get full text
    Online Article RSS Article
  8. Development and applications of oncolytic Maraba virus vaccines

    Published in Oncolytic Virotherapy (2018)
    Get full text
    Online Article RSS Article
  9. Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme

    Published in Oncolytic Virotherapy (2018)
    Get full text
    Online Article RSS Article
  10. Oral poliovirus vaccine-induced programmed cell death involves both intrinsic and extrinsic pathways in human colorectal cancer cells

    Published in Oncolytic Virotherapy (2018)
    Get full text
    Online Article RSS Article
  11. Three-dimensional tumor cell cultures employed in virotherapy research

    Published in Oncolytic Virotherapy (2018)
    Get full text
    Online Article RSS Article
  12. Oncolytic virus and PD-1/PD-L1 blockade combination therapy

    Published in Oncolytic Virotherapy (2018)
    Get full text
    Online Article RSS Article
  13. Current understanding of reovirus oncolysis mechanisms

    Published in Oncolytic Virotherapy (2018)
    Get full text
    Online Article RSS Article
  14. Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer

    Published in Oncolytic Virotherapy (2018)
    Get full text
    Online Article RSS Article
  15. Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodies

    Published in Oncolytic Virotherapy (2018)
    Get full text
    Online Article RSS Article
  16. The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses

    Published in Oncolytic Virotherapy (2018)
    Get full text
    Online Article RSS Article
  17. Oncolytic virotherapy in upper gastrointestinal tract cancers

    Published in Oncolytic Virotherapy (2018)
    Get full text
    Online Article RSS Article
  18. Potential of oncolytic viruses in the treatment of multiple myeloma

    Published in Oncolytic Virotherapy (2018)
    Get full text
    Online Article RSS Article
  19. Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect

    Published in Oncolytic Virotherapy (2017)
    Get full text
    Online Article RSS Article
  20. Curative effect of HF10 on liver and peritoneal metastasis mediated by host antitumor immunity

    Published in Oncolytic Virotherapy (2017)
    Get full text
    Online Article RSS Article